Post-Vax New and Recurrent Cancers Suggest Immune System Changes

Written by Marina Zhang on August 23, 2022. Posted in Current News

Since receiving Moderna COVID-19 vaccines, Bonnie Eisenberg experienced relapse of her breast cancer 8 years after being in remission.

The 73-year-old was diagnosed with stage 2 breast cancer in 2012. After successful treatment, she had been in remission since 2014.

Ever since then, her doctor has measured tumor marker levels in her body to monitor for relapse.

Tumor markers are usually proteins that indicate possible tumor or cancer growth. High levels of tumor markers may indicate cancer but it is not definitive.

There are many markers that can be tested, but the one that her doctor particularly focused on was the carcinoembryonic antigen (CEA), a tumor marker common to cancers of the breast, colon and rectum, prostate, ovary, lung, thyroid, and liver.

Since 2014, Eisenberg dutifully took monthly CEA tests along with others. The tests continuously returned with numbers in the normal range, which her doctor said was from 0 to 4.0 ng/mL.

Eisenberg’s average CEA results had been at 0.4 ng/mL, indicating her cancer was under control.

“Everything’s been going fine,” Eisenberg told The Epoch Times, “I was one of his best patients. He never worried about me.”

However, that changed after she got vaccinated. She received her first Moderna shot in January 2021 and experienced various common adverse effects including fever, shakes, “you name it, I had it,” she said.

That month, her CEA test rose to 3.7 ng/mL.

However, since it was still within the normal range, both Eisenberg and her doctor were not concerned.

After all, tumor cells are not limited to cancer patients. It is a known fact that everyone can have cancerous cells; what matters is whether the immune system can keep the cancer in check.

Eisenberg took her second shot in February 2021 and again suffered the same adverse effects.

Her CEA numbers jumped to 5.2 ng/mL that month.

This took her out of the normal range. Yet because Eisenberg has been such a stable patient, and because her result was so close to the normal range, both she and her doctor dismissed the results.

“Maybe I should have been a little more on the doctor. Since I was so good. We weren’t really that concerned about it.”

Boosters became available in October 2021. Eisenberg was not happy to take it given her previous adverse reactions, but she and her husband took it anyway. She experienced the same terrible adverse reactions.

In October 2021 and December 2021, she had CEA tests taken.

On Dec. 13, 2021 at 8 o’clock in morning, she received a call from her doctor. He was very concerned.

“When you’re getting a phone call that early in the morning, something’s wrong. He says to me: ‘Bonnie, we have to scan you.’ What’s the matter? [I asked]. My mark was up to 17.6 [ng/mL]—I was in trouble.”

Eisenberg was immediately sent for a CAT scan, as well as MRI and PET scans.

On the PET scans, it showed that her previously dormant breast cancer has “metastasized,” meaning that it has spread to locations outside the breast.

“When he hit me with this, even now … it’s just a very hard thing to accept. It’s just something that should have never taken place.”

“[The cancer] went to all my bones … it didn’t go to any of my body organs, but it was over every bone you could think of. On the PET scan I lit up like a Christmas tree.”

A metastasizing breast cancer would automatically put her in stage 4, the worst stage for cancers.

Eisenberg is convinced that the vaccine is responsible for her cancer recurrence. The increase in CEA levels correlated well with her vaccine timeline, and she is adamant that she will not get any more vaccinations, fearing that she will really die from it.

In the same month (December 2021), Eisenberg started targeted therapy. The main medication she takes for her cancer costs about $14,000 a month “but I just have a little copayment coverage for it.”

She also has a hormone blocker as well as a monthly injection of denosumab ($3,000 each) to prevent bone fractures. Luckily, her insurance covers the cost of denosumab.

Eisenberg has responded very well to her drugs, and her cancer is back in remission now.

Since she started treatment again, her CEA numbers dropped from 4.7 in January 2022 to below 1 ng/mL in June 2022. Her numbers are just like how she was before vaccination.

The bright spots representing cancer cells are also gone on her new PET scans.

Nonetheless, things have not returned to normal; the drug side effects Eisenberg complains of are likely to accompany her for the rest of her life.

“I have to be on [medication] for the rest of my life. I can’t stop it … he [the doctor] can lower the milligrams and stuff like that … but you always have to be watched. What I have is not going away.”

Her breast cancer medication reduces white blood cell counts, significantly weakening her immune system and puts her at risk of infections. This new worry hangs on Eisenberg’s mind, and in crowded places, she feels compelled to put on a face mask.

The drug also causes her hair to thin, and as a “hair girl,” Eisenberg is bothered by the reality that she can no longer straighten her hair.

The denosumab injections can also cause loss of bone mass leading to eventual breakdown. Eisenberg is glad to have greater intervals introduced between each injection and possible reduced dosages for her medications.

Given her stage 4 relapse, Eisenberg is considered fortunate to be back in remission.

Eisenberg shared her experience with other women also in remission who have not been recommended to do monthly tests, or women who responded very poorly to potent breast cancer treatments.

She hopes that her story will be able to help others so that the same does not happen to them.

“Whatever erupted inside me from the shot, something happened because they don’t even know what it does to the immune system … [the doctors, people at Moderna] don’t even know; there’s no answers. Nobody has any answers. I don’t care who you talk to. You’re not gonna get an answer. They don’t know.”

“There’s possibly other girls like me now. They don’t even know what’s happening inside them because if they’re not tested properly, they’re not going to know.”

In the history of the Vaccine Adverse Event Reporting System (VAERS), a total of 93 breast cancer cases have been reported as an adverse effect of a vaccine, of which 77 of the cases are reported after COVID-19 vaccines.

What Current Research Shows Us

The current research suggests the COVID shots altered the innate immune system, which is likely to alter the adaptive immune system.

Within the body, we have the innate immune cells that are quick-acting, inflammatory, and target all foreign molecules the same way.

Some of these innate immune cells will eventually activate adaptive immune cells, called the T and B cells. These cells begin to work a few days after infection and require activation from innate immune cells to function properly. These T and B cells target infections and cancers through specific and varied pathways. They create an immune memory afterwards so that the immune system will be able to act faster the next time.

Innate Immune System Alterations: Interferons

Interferons (IFN) are antiviral proteins.  There are three major types: type I, II, and III, categorized based on the receptors each IFN binds to.

One of the most important IFN is type 1 IFN; it acts globally, targeting many tissues and organs to protect from infections, autoimmune diseases, as well as cancers.

Studies show that they are particularly important in the early response to infection and cancer.

“Impaired type I IFN signaling is linked to many disease risks, most notably cancer, as type 1 IFN signaling suppresses proliferation of both viruses and cancer cells by arresting the cell cycle,” the authors, led by Dr. Stephanie Seneff from the Massachusetts Institute of Technology wrote.

IFN-alpha and IFN-beta are type 1 IFNs; these molecules alert other cells of a virus or cancer, and also stop infected and cancerous cells from proliferating, causing diseased cells to die.

However, research on spike protein and mRNA vaccines suggests that IFN-alpha action may be impaired when exposed to spike protein.

A study that exposed human cells to spike protein DNA to induce the cell to produce spike protein found that the cell shipped out the spike protein with two forms of microRNAs (miRNAs) that inhibited molecules that activated IFN-alpha/beta.

miRNA are short strands of RNA molecules that bind to the DNA in cells and can therefore regulate cell activity. These two miRNA inhibited an essential protein that activates the IFN-alpha/beta pathway. This implies that vaccinated individuals will have a reduced IFN-alpha/beta response and poorer immune clearance.

Seneff said that the reduced symptoms in the vaccinated are likely because of this reduced pathway, since the initial symptoms of COVID-19 are caused by actions of the interferon action. This is why many vaccinated individuals are getting infected with rebound symptoms.

“[The vaccinated] don’t get the symptoms … don’t feel as sick, but actually, you’re spreading the disease like crazy because you’re not fighting it off.”

This also means that the virus will stick around in vaccinated individuals for longer, and if the disease is not cleared after a long period of time, it can cause severe disease down the line.

This hypothesis also concordant with hospitalization and mortality rates in New South Wales, an Australian state where over 95 percent of the population has been fully vaccinated, with many people receiving one or two boosters.

Hospitalitization rates and mortality rates are significantly higher in the boosted and fully vaccinated cohort, with lower rates in the unvaccinated and patients that have only received one dose.

Reduced T-Cell Response

T-cells and B-cells are adaptive immune cells, meaning that they engage in specific and targeted attacks rather than attacking all foreign invaders the same way, which is what innate immune cells do.

Both cell types are very powerful, but both need to be activated first through innate immune system pathways to develop strong, specified attacks.

Killer T-cells engage in close combat with diseased and cancerous cells by punching holes into them whereas B plasma cells work long-range, releasing antibodies into fluids in the body to surround and neutralize toxins, bacteria, and viruses. B-cells also play a role in cancer, though their function and importance are not well understood.

T-cells have been extensively studied for the important role they play in cancer by killing cancer cells directly. The activity of T-cells have often been used to predict disease outcomes in cancer patients.

However, recent studies have shown that innate immune function has been altered in those injected with the COVID shots. A preprint study found receptors that activate T-cell action, including TLR7/8 (toll like receptors 7 and 8), are reduced in vaccinated individuals.

Further, a Chinese study of people who have been vaccinated with the spike protein-inducing COVID-19 shots found that gene activity for what proteins and pathways are turned on and off have changed across most immune cells.

This raises questions about our traditional understanding of the innate immune cell to T-cell activation pathway and whether vaccinated individuals will have an immune system that responds similarly to how it was before vaccination.

The study found T-cell activity was reduced as well as an increased inflammatory response in the immediate weeks following vaccination, which, in the long-term, puts people at risk for cancer.

“These data suggested that after vaccination, at least by day 28, other than generation of neutralizing antibodies, people’s immune systems, including those of lymphocytes (T-cells, B-cells, natural killer cells) and monocytes (innate immune cells), were perhaps in a more vulnerable state,” the authors wrote.

These findings overlap with pathologist Dr. Ryan Cole’s observations at his medical laboratory, Cole Diagnostics.

Cole told Jan Jekielek on American Thought Leaders that after vaccinations started rolling out in the older population, he noticed the reappearance of Molluscum contagiosum, a parapoxvirus that most people get in childhood and is kept in check by the immune system from the teenage years onward.

Though the uptick is unusual, as Cole saw more cases he grew concerned that the vaccines may be driving a form of “immune dysregulation,” meaning a possible breakdown to established immune controls. Since these viruses are normally kept in check by T-cells, which also keep cancers in check, a loss of immune memory against viruses could be a sign of loss of control in cancers.

“About a month or two later, all of a sudden there are certain types of cancers that I commonly see in the laboratory, after 500,000 patients … I started seeing endometrial cancers go up and there’s certain type … Melanomas, I started seeing thicker and earlier as well.”

Since then he has shared his findings in other lectures and found that other doctors and nurses around the world have made similar observations of increased rates of cancer cases.

An analysis by The Expose on VAERS data also indicated an uptick of cancer after COVID-19 vaccines by 143 thousand percent.

See more here: theepochtimes

Please Donate Below To Support Our Ongoing Work To Expose The Lies About COVID19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.